 | Up a level |
2022
Henes, J., Saur, S., Kofler, D. M., Kedor, C., Meisner, C., Krusche, M., Koetter, I., Xenitidis, T., Schulze-Koops, H. and Feist, E. (2022). TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER - DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY. Ann. Rheum. Dis., 81. S. 30 - 32. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2021
Kreuter, M., Bonella, F., Kathrin, K., Henes, J., Siegert, E., Riemekasten, G., Blank, N., Pfeiffer, C., Mueller-Ladner, U., Kreuter, A., Korsten, P., Juche, A., Schmalzing, M., Worm, M., Jandova, I., Susok, L., Schmeiser, T., Guenther, C., Keyszer, G., Ehrchen, J., Ramming, A., Koetter, I., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2021). LONG-TERM OUTCOME OF SSC ASSOCIATED ILD: IMPROVED SURVIVAL IN PPI TREATED PATIENTS. Ann. Rheum. Dis., 80. S. 670 - 672. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Kuster, S., Jordan, S., Elhai, M. D., Held, U., Steigmiller, K., Bruni, C., Iannone, F., Vettori, S., Siegert, E., Rednic, S., Codullo, V., Airo, P., Braun-Moscovici, Y., Hunzelmann, N., Salvador, M. J., Riccieri, V., Gheorghiu, A. M., Alegre Sancho, J. J., Romanowska-Prochnicka, K., Castellvi, I., Koetter, I., Truchetet, M. E., Lopez-Longo, F. J., Novikov, P., Giollo, A., Shirai, Y., Belloli, L., Zanatta, E., Hachulla, E., Smith, V., Denton, C., Ionescu, R., Schmeiser, T., Distler, J. H. W., Gabrielli, A., Hoffmann-Vold, A. M., Kuwana, M., Allanore, Y. and Distler, O. (2021). EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT. Ann. Rheum. Dis., 80. S. 685 - 687. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2020
Kreuter, M., Bonella, F., Riemekasten, G., Mueller-Ladner, U., Henes, J., Siegert, E., Guenther, C., Koetter, I., Blank, N., Pfeiffer, C., Schmalzing, M., Zeidler, G., Korsten, P., Susok, L., Juche, A., Worm, M., Jandova, I., Ehrchen, J., Sunderkoetter, C., Keyszer, G., Ramming, A., Schmeiser, T., Kreuter, A., Kuhr, K., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2020). DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK. Ann. Rheum. Dis., 79. S. 1585 - 1586. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2018
Moinzadeh, P., Riemekasten, G., Blank, N., Henes, J., Koetter, I., Siegert, E., Pfeiffer, C., Zeidler, G., Schmalzing, M., Guenther, C., Susok, L., Worm, M., Kreuter, A., Sunderkoetter, C., Mueller-Ladner, U., Juche, A., Aberer, E., Schmeiser, T., Krieg, T., Kuhr, K. and Hunzelmann, N. (2018). SSC IN OLDER AGE: FREQUENT AND WITH A DIFFERENT PHENOTYPE. DATA OF THE GERMAN NETWORK FOR SYSTEMIC SCLEROSIS. Ann. Rheum. Dis., 77. S. 1109 - 1110. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2017
Belz, D., Moinzadeh, P., Blank, N., Siegert, E., Henes, J., Worm, M., Sunderkoetter, C., Schmalzing, M., Kreuter, A., Gunther, C., Susok, L., Zeidler, G., Koetter, I., Mueller-Ladner, U., Krieg, T., Juche, A., Schmeiser, T., Riemekasten, G., Aberer, E., Gaebelein-Wissing, N., Distler, J. H. W., Sardy, M., Pfeiffer, C., Kuhr, K. and Hunzelmann, N. (2017). EVALUATION OF FREQUENCY AND TYPE OF PHYSICAL THERAPY IN MORE THAN 3400 PATIENTS WITH SYSTEMIC SCLEROSIS. Ann. Rheum. Dis., 76. S. 1106 - 1107. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Moinzadeh, P., Blank, N., Siegert, E., Henes, J., Worm, M., Sunderkoetter, C., Schmalzing, M., Kreuter, A., Gunther, C., Susok, L., Zeidler, G., Koetter, I., Mueller-Ladner, U., Krieg, T., Juche, A., Schmeiser, T., Riemekasten, G., Aberer, E., Gaebelein-Wissing, N., Distler, J. H. W., Sardy, M., Pfeiffer, C., Kuhr, K., Hunzelmann, N., Bonella, F. and Kreuter, M. (2017). DIFFUSING CAPACITY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SYSTEMIC SCLEROSIS - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLEROSIS. Ann. Rheum. Dis., 76. S. 1110 - 1111. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2015
Albrecht, K., Englbrecht, M., Baerwald, C., Feist, E., Fleck, M., Gromnica-Ihle, E., Koehler, L., Koetter, I., Kneitz, C., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B., Mueller-Ladner, U. and Tarner, I. H. (2015). National and Multinational Evidence-based Recommendations for Medical Pain Management in Inflammatory Joint Disease: Systematic Literature Research and Expert Opinion in the 3e Initiative. Aktuelle Rheumatol., 40 (1). S. 67 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9940
2014
Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J. H. W., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Kuhr, K., Lorenz, H. -M., Meier, F., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Schmalzing, M., Sunderkoetter, C., Susok, L., Tarner, I. H., Vaith, P., Worm, M., Wozel, G., Zeidler, G. and Hunzelmann, N. (2014). SSC-OVERLAP SYNDROMES: A DISTINCT CLINICAL SUBGROUP WITH SIGNIFICANT DIFFERENCES IN DISEASE PROGRESSION COMPARED TO LSSC AND DSSC PATIENTS. Clin. Exp. Rheumatol., 32 (2). S. S119 - 2. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X
Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J. W., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Kuhr, K., Lorenz, H. M., Meier, F., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Schmalzing, M., Sunderkoetter, C., Susok, L., Tarner, I. H., Vaith, P., Worm, M., Zeidler, G. and Hunzelmann, N. (2014). SSc-overlap syndromes: a distinct clinical subgroup with significant differences in disease progression compared to lSSc and dSSc patients. Data of the German Network for Systemic Scleroderma (DNSS). Exp. Dermatol., 23 (3). S. E13 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moinzadeh, P., Elisabeth, A., Blank, N., Distler, J., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Hellmich, M., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Susok, L., Worm, M., Wozel, G., Zeidler, G., Sunderkoetter, C. and Hunzelmann, N. (2014). ANALYSIS OF REAL LIFE VASOACTIVE THERAPY IN OVER 3000 PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) REVEALS CONSIDERABLE UNDERTREATMENT AND SIGNIFICANT CHANGES OF TREATMENT PRACTICE SINCE 2004. Ann. Rheum. Dis., 73. S. 564 - 565. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Tarner, I. H., Albrecht, K., Fleck, M., Gromnica-Ihle, E., Keysser, G., Koehler, L., Koetter, I., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B. and Mueller-Ladner, U. (2014). Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative. Z. Rheumatol., 73 (4). S. 363 - 374. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2013
Witt, M., Grunke, M., Proft, F., Baeuerle, M., Aringer, M., Burmester, G., Chehab, G., Fiehn, C., Fischer-Betz, R., Fleck, M., Freivogel, K., Haubitz, M., Koetter, I., Lovric, S., Metzler, C., Rubberth-Roth, A., Schwarting, A., Specker, C., Tony, H-P, Unger, L., Wassenberg, S., Doerner, T. and Schulze-Koops, H. (2013). Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). Lupus, 22 (11). S. 1142 - 1150. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0962